Rocío García-Carbonero

Rocío García-Carbonero, MD, PhD is Head of the Gastrointestinal and Endocrine Tumors Unit at Hospital Universitario 12 de Octubre and Professor of Oncology at Complutense University of Madrid, where she leads one of Spain's premier NET and neuroendocrine carcinoma (NEC) clinical and research programs. She is internationally recognized for her expertise in high-grade NETs and NECs — a heterogeneous group of aggressive tumors for which therapeutic options remain limited — and has led investigational studies and evidence syntheses that have shaped ENETS and ESMO guideline recommendations for these challenging cancers. Dr. García-Carbonero has chaired the ENETS NEC working group and authored consensus guidelines for diagnosis and treatment of poorly differentiated neuroendocrine carcinomas, which represent the most authoritative international recommendations for this subgroup. Her research has characterized the molecular biology, Ki-67 thresholds, and platinum sensitivity of high-grade GEP-NETs and NECs, contributing to the WHO 2019 classification framework. She has also led prospective studies of temozolomide and alkylating agent combinations in well-differentiated G3 NETs, a particularly undercharacterized population. A recipient of several national and international awards for oncology research, Dr. García-Carbonero serves on the ESMO Faculty for GI and NET cancers, is a past Scientific Committee Chair for ENETS, and has published over 180 peer-reviewed articles spanning basic, translational, and clinical NET research.